Berichten in American Law

Law, Ethics and Policy of Quantum & AI in Healthcare and Life Sciences published at Harvard, Stanford and European Commission

A collaborative research initiative by scholars from Stanford, Harvard, and MIT, published by the Petrie-Flom Center at Harvard Law School, the Stanford Center for Responsible Quantum Technology, and the European Commission, delves into the complex regulatory and ethical landscape of integrating quantum technologies and artificial intelligence (AI) into the healthcare and life sciences sectors. This series of policy guides and analyses, authored by an interdisciplinary team including Mauritz Kop, Suzan Slijpen, Katie Liu, Jin-Hee Lee, Constanze Albrecht, and I. Glenn Cohen, offers a comprehensive examination of the transformative potential and inherent challenges of this technological convergence.

Regulating Quantum & AI in Healthcare and Medicine: A Brief Policy Guide

This body of research, examining the entangled legal, ethical, and policy dimensions of integrating quantum technologies and AI into healthcare, is articulated across a series of publications in leading academic and policy forums. These works collaboratively build a comprehensive framework for understanding and navigating the future of medicine. A related policy guide was also published on the European Commission's Futurium platform, further disseminating these findings to a key international policymaking audience. The specific publications include:

1. A Brief Quantum Medicine Policy Guidehttps://blog.petrieflom.law.harvard.edu/2024/12/06/a-brief-quantum-medicine-policy-guide/

2. How Quantum Technologies May Be Integrated Into Healthcare, What Regulators Should Considerhttps://law.stanford.edu/publications/how-quantum-technologies-may-be-integrated-into-healthcare-what-regulators-should-consider/

3. EU and US Regulatory Challenges Facing AI Health Care Innovator Firmshttps://blog.petrieflom.law.harvard.edu/2024/04/04/eu-and-us-regulatory-challenges-facing-ai-health-care-innovator-firms/

4. Regulating Quantum & AI in Healthcare: A Brief Policy Guidehttps://futurium.ec.europa.eu/en/european-ai-alliance/document/regulating-quantum-ai-healthcare-brief-policy-guide

by Mauritz Kop, Suzan Slijpen, Katie Liu, Jin-Hee Lee, Constanze Albrecht & I. Glenn Cohen

Forging the Future of Medicine: A Scholarly Perspective on the Law, Ethics, and Policy of Quantum and AI in Healthcare

The research posits that the fusion of AI with second-generation quantum technologies (2G QT)—which harness quantum-mechanical phenomena like superposition and entanglement—is poised to revolutionize precision medicine. This synergy of quantum computing, sensing and simulation with artificial intelligence promises hyper-personalized healthcare solutions, capable of tackling intricate medical problems that lie beyond the grasp of classical computing. The potential applications are vast, spanning from accelerated drug discovery and development workflows and enhanced diagnostic imaging to rapid genome sequencing and real-time health monitoring. For instance, quantum simulations could model molecular interactions to create more effective pharmaceuticals, while quantum dots may offer novel platforms for targeted cancer therapies and treatments for neurodegenerative conditions by overcoming the blood-brain barrier.

However, the authors caution that these groundbreaking advancements are accompanied by significant ethical, legal, socio-economic, and policy (ELSPI) implications. The emergence of Quantum Artificial Intelligence (QAI), Quantum Machine Learning (QML), and Quantum Large Language Models (QLLM) is expected to amplify these ELSPI concerns. The dual-use nature of these technologies, such as their potential application in gain-of-function research, necessitates a principled and human-centric governance approach.

Meer lezen

Academics, Artificial Intelligence, European Law, American Law, Stanford, Harvard, Medical Devices, Medicine, HealthcareMauritz Kop6 december 2024quantum, AI, healthcare, medicaldevices, law, ethics, policy, governance, regulation, medicine, EMA, FDA, Harvard, Stanford, Mauritz Kop

Mauritz Kop Consults Senator Mark Warner on AI & Quantum Technology Policy

Washington D.C., January 4, 2022—As the United States Congress grapples with the complex challenges of regulating artificial intelligence and quantum technology, leading policymakers are seeking expert guidance to inform a robust and forward-thinking national strategy. On January 4, 2022, Mauritz Kop, a distinguished scholar in the field of technology law and governance, was consulted by the legal team of U.S. Senator Mark Warner (D-VA) to provide strategic insights on both AI and quantum technology policy.

This consultation highlights the growing recognition in Washington of the need for deep, interdisciplinary expertise to navigate the geopolitical, economic, and security dimensions of these transformative technologies. Senator Warner's team reached out to Kop based on his influential scholarship, including his extensive work at Stanford on the EU AI Act and the need for a strategic democratic tech alliance, his advisory role for the European Commission led by Ursula von der Leyen on the AI Act and Data Act, and his foundational article in the Yale Journal of Law & Technology proposing a comprehensive legal-ethical framework for quantum technology.

Senator Mark Warner: A Leader on Technology and National Security

Senator Mark Warner's engagement on these issues is both significant and timely. As the Chairman of the Senate Select Committee on Intelligence, he is at the forefront of addressing the national security implications of emerging technologies. His work involves overseeing the U.S. Intelligence Community and ensuring it is equipped to handle the threats and opportunities of the 21st century, where technological competition with nations like China is a central concern.

The Senate Select Committee on Intelligence has a broad mandate that includes analyzing intelligence on the technological capabilities of foreign powers and assessing the vulnerabilities of U.S. critical infrastructure. Senator Warner has been a vocal proponent of developing a national strategy for AI and quantum to maintain the United States' competitive edge and to ensure that these technologies are developed and deployed in a manner consistent with democratic values. This consultation with Mauritz Kop reflects the Senator's commitment to drawing on leading academic research to shape sound, bipartisan policy.

AI Policy: A Transatlantic, Risk-Based Approach that Lets Innovation Breathe

A key focus of the consultation was Kop's analysis of the European Union's AI Act. His Stanford publications argue for a balanced, pro-innovation regulatory model that can serve as a blueprint for international cooperation. Good governance and sensible legislation should incentivize desired behavior and simultaneously create breathing room for sustainable, beneficial innovation to flourish.

Quantum Governance: Establishing a Legal-Ethical Framework

The discussion also delved into the governance of quantum technology, drawing on Kop's seminal work in the Yale Journal of Law & Technology. Recognizing that quantum is rapidly moving from the theoretical to the practical, he stressed the urgency of establishing a legal-ethical framework before the technology is widely deployed and locked-in.

The consultation with Senator Warner's office represents a critical intersection of academic scholarship and high-level policymaking. As the United States charts its course in the era of AI and quantum, the insights provided by experts like Mauritz Kop are invaluable in ensuring that the nation's strategy is not only competitive but also responsible, ethical, and firmly rooted in democratic principles.